ClinicalTrials.govpublic full text
Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN
blastic plasmacytoid dendritic cell neoplasm, myeloproliferative neoplasm, antibody drug conjugate, other hematologic malignancies, myeloproliferative neoplasms, cd123, mds, relapsed, refractory, acute lymphocytic leukaemia, acute myeloid leukemia, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 902112
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.